Person

Arpa Garay

Formerly Chief Commercial Officer, Moderna

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$394K

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • MRNA
    Moderna
    Chief Commercial Officer
    Jun 2022 – last filing Dec 2023
  • MRK
    Merck & Co.
    SVP Human Health Global Mktg.
    Mar 2022 – last filing May 2022

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Dec 6, 2023MRNASale564$78.34$44K
Sep 6, 2023MRNASale574$108.40$62K
Jun 6, 2023MRNASale2,290$125.75$288K

SEC reporting-owner ID (CIK) 1916360 · all filings on EDGAR